KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Notes Payables: 2022-2023

Historic Notes Payables for Medpace Holdings (MEDP) over the last 1 years, with Jun 2023 value amounting to $55.0 million.

  • Medpace Holdings' Notes Payables fell 77.97% to $55.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $55.0 million, marking a year-over-year decrease of 77.97%. This contributed to the annual value of $50.0 million for FY2022, which is N/A change from last year.
  • As of Q2 2023, Medpace Holdings' Notes Payables stood at $55.0 million, which was down 52.17% from $115.0 million recorded in Q1 2023.
  • In the past 5 years, Medpace Holdings' Notes Payables ranged from a high of $249.7 million in Q2 2022 and a low of $50.0 million during Q4 2022.
  • Its 2-year average for Notes Payables is $121.9 million, with a median of $115.0 million in 2023.
  • Data for Medpace Holdings' Notes Payables shows a maximum YoY tumbled of 77.97% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Medpace Holdings' Notes Payables stood at $50.0 million in 2022, then crashed by 77.97% to $55.0 million in 2023.
  • Its Notes Payables was $55.0 million in Q2 2023, compared to $115.0 million in Q1 2023 and $50.0 million in Q4 2022.